The FY22 Defense Appropriations Act is anticipated to provide funding for the Peer Reviewed Alzheimer’s Disease Research Program (PRARP) to support research that addresses the long-term implications of military service as they pertain to Alzheimer’s disease (AD) and related dementias (ADRD) for Service Members, Veterans, and the general public.  The managing agent for the anticipated program announcements/ funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command (USAMRDC).

The FY22 PRARP funding opportunity announcements for the following award mechanisms will be posted on the Grants.gov website

Applications submitted to the FY22 PRARP must address one or more of the following Focus Areas:

• Individual, caregiver, and family support:  Research and resources focused on long-term care, quality of life, psychosocial wellness and support, and community and home resources supporting aging-in-place and community living for individuals living with dementia, their families, and care partners.  Family is broadly defined to include family of choice as well.  Study population diversity is strongly encouraged.  Community-based participatory research inclusion is strongly preferred.
• Environmental, Diagnostic, and Prognostic Factors:  Research to better detect, diagnose, and predict long-term outcomes and risk factors associated with AD/ADRD following military service and/or traumatic brain injury (TBI).  Research of interest may include, but is not limited to:

○         Identification and validation of biomarkers for diagnosis and prognosis of AD and ADRD:  including but not limited to fluid, tissues, imaging, device, and psychosocial, or a combination thereof.

○         Risk and resiliency factors for development of AD/ADRD during and after military service, such as genetic, physiological, psychosocial, and life history. 

○         Epidemiological studies examining TBI and/or military service-related factors, including TBI and AD/ADRD development.

• Fundamental research to better understand the etiology, risk, and comorbidities for AD/ADRD after TBI.

Funding Opportunities-FY22 PRARP, Congressionally Directed Medical Research Programs (CDMRP) (army.mil)

, NEW: Investigator-Initiated Research Award – Letter of Intent due June 17, 2022

Single Principal Investigator (PI) Option

Independent investigators at all academic levels (or equivalent).

Early-Career Investigator Partnering PI Option

The Early-Career Investigator PI must be an independent investigator within 10 years of their terminal degree by the time of the application submission deadline (excluding time spent in residence or on family medical leave) or new to the field

 Supports studies that will make important contributions to TBI and/or military-service-related factors as they pertain to AD/ADRD research, patient care, and quality of life.

 Clinical trials are NOT allowed.

 Community collaboration is required for projects involving clinical research.

 Applications must address at least one of the following FY22 PRARP Focus Areas:

– Individual, caregiver, and family support (animal studies are NOT allowed for this Focus Area)

– Diagnostic, environmental, and prognostic factors

– Foundational research

 The maximum allowable funding for the entire period of performance is $750,000 for total costs.

 Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

 The maximum period of performance is 3 years.

NEW: Translational Research Award – Letter of Intent due June 17, 2022

Independent investigators at or above the level of Assistant Professor (or equivalent).

 Supports translational research that will accelerate the movement of promising products and knowledge in AD/ADRD research into clinical applications, including healthcare products and interventions, technologies, behavioral modalities, and/or clinical practice guidelines.

 Supports both preclinical-to-clinical and clinical research-to-clinical care translation.

 Clinical trials are NOT allowed.

 Preliminary data are required.

 Community collaboration is required for projects involving clinical research.

 Applications must address at least one of the following FY22 PRARP Focus Areas:

– Individual, caregiver, and family support (animal studies are NOT allowed for this Focus Area)

– Diagnostic, environmental, and prognostic factors

– Foundational research

• The maximum allowable funding for the entire period of performance is $750,000 for total costs.
• Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
• The maximum period of performance Is 3 years.

Accelerating Diagnostics Research Award – Letter of Intent due June 17, 2022

Independent investigators at or above the level of Assistant Professor (or equivalent).

Supports high-impact advancement of robust diagnostic and/or prognostic factors pertaining to Alzheimer’s disease/Alzheimer’s disease-related dementias (AD/ADRD) following military service and/or traumatic brain injury (TBI).

 Studies are required to prospectively recruit study participants.

 Community collaboration is required.

 Preliminary data are required.

 Animal research is prohibited.

 Clinical trials are NOT allowed.

 Applications must address the following FY22 PRARP Focus Area:

– Diagnostic, environmental, and prognostic factors

 The maximum allowable funding for the entire period of performance is $2,500,000 for total costs.

 Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.

 The maximum period of performance is 4 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.  All applications must conform to the final funding opportunity announcements available for downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism will also be found on Grants.gov.  A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the PRARP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk
301-682-5507
help@eBrap.org

For more information, please contact Jill Sherman, International Research Facilitator at intl.research@lakeheadu.ca.

This program is delivered in partnership with the Natural Sciences and Engineering Research Council of Canada (NSERC) and is an extension of the Idea to Innovation (I2I) Market Assessment Grant.

This 4-month program offers:

• Curriculum (lectures, talks, and workshops) designed to introduce researchers to the world of entrepreneurship.

• An advisor network (founders, industry leaders, and service providers) to help researchers through their business venture. 

• A community of like-minded entrepreneurs.

• $15,000 in funding to support researchers in getting their idea off the ground.

• The opportunity for future funding through the NSERC I2I Phase I grant. 

Applications close on June 27th, 2022.

If you have any questions or concerns, please feel free to reach out to our Learning & Recruitment Specialist, Wesley Kosiba, wkosiba@ryerson.ca.

The Burroughs Wellcome Fund Climate and Health Interdisciplinary Award provides support for collaborative exploratory work that opens new ground for comprehensively assessing or mitigating the impacts of climate change on human health. This program will support both individual scientists and multi-investigator teams. Early career faculty and postdoctoral fellows nearing their transition to independence are especially encouraged to apply, whether individually or within teams.

Our goal is to prime new discoveries in areas that are difficult to reach through discipline-specific, silo-driven approaches. Through this program, we will provide flexible funding for conceiving and piloting work that will grow into productive and informative collaborations among researchers approaching connected questions from fields that usually do not interact.

For more information, please contact Jill Sherman, International Research Facilitator, at intl.research@lakeheadu.ca.

The Burroughs Wellcome Fund aims to stimulate the growth of new connections between scholars working in largely disconnected fields who might together change the course of climate change’s impact on human health. Over the next two years, we will dedicate $1M to supporting small, early-stage grants of $2,500 - $50,000 toward achieving this goal.

Proposals will be accepted on a rolling basis through August 30, 2023. A review will be conducted quarterly. After each quarterly review, we will support, decline, or send proposals back to applicants for revision, but may hold some proposals over for a future review. Recommended revisions may include suggestions that separate groups of applicants submitting similar proposals work together to develop a single proposal or that applicants consider becoming involved in efforts aligned with work funded in earlier quarters.

For more information, please contact Jill Sherman, International Research Facilitator, at intl.research@lakeheadu.ca.

In this call for applications, we seek to support high-risk, high reward research projects and highly innovative and creative research ideas that have the potential to advance knowledge in neural development and neurodevelopmental disorders. This grant will provide seed funding for proposals that test new hypotheses, explore new approaches to intractable problems or challenge prevailing paradigms. We are looking for distinctive and novel approaches, including development of techniques or technologies that could enable new discoveries.

Supporting the next generation of brain researchers in Canada is needed to ensure the success of the Canadian brain research ecosystem. The Brain Canada Rising Stars Trainee Awards aim to recognize the excellent research being conducted at Canadian institutions by graduate students (M.Sc., Ph.D.), postdoctoral fellows, and residents in all fields spanning neuroscience research.

2022 Trainee Award Opportunities :

Shireen and Edna Marcus Excellence Award

• Purpose: To provide financial support to promising graduate students, postdoctoral fellows and/or residents conducting research in autism.
• Amount of award: $4,500 per award for one year, non-renewable.
• Number of awards: Up to 1 award.

Dr. Hubert van Tol Travel Fellowship

• Purpose: To allow graduate students (M.Sc., Ph.D.) and postdoctoral fellows to attend a major international conference/symposium or training course.
• Amount of award: $5,000 per one award, non-renewable.
• Number of awards: Up to 4 awards.

Canadian Consortium for the Investigation of Cannabinoids (CCIC) Neuroscience Fellowship in Cannabis and Cannabinoid Research

• Purpose: To provide financial support to graduate students (M.Sc., Ph.D.), postdoctoral fellows, or residents conducting neuroscience research at a Canadian institution in the field of cannabis/cannabinoid research.  
• Amount of award: $10,000 per award for one year, non-renewable.
• Number of awards: Up to 2 awards.

Dr. Matthew Galati Brain Changer Award

• Purpose: To provide financial support to graduate students (M.Sc., Ph.D.), postdoctoral fellows, or residents conducting clinical implementation research at a Canadian institution in the field of acquired brain injury.  
• Amount of award: $10,000 per award for one year, non-renewable.
• Number of awards: Up to 2 awards.

Evidence clearly shows that increasing equity, diversity, and inclusion (EDI) in research environments enhances excellence, innovation, and creativity. Brain Canada is committed to excellence through equity and encourages applicants of diverse backgrounds to apply to this funding opportunity, which will promote the expression of diverse perspectives, approaches, and experiences, including those of underrepresented groups.

For more information on the Brain Canada Rising Stars Trainee Awards, please consult the Request for Application. 

Deadline for receipt of Applications: June 2, 2022 at 16:00 ET

Should you have any questions, please contact programs@braincanada.ca

The call is open! Mitacs Globalink Research Internship (GRI) is now accepting faculty project submissions for Summer 2023. GRI pairs faculty in Canada with international undergrads for 12-week research projects from May to October.

The Globalink program builds global networks and experiences, and positions Canada as a top destination for innovation and research among international students.

•    All disciplines are eligible
•    Top-ranked senior undergrads travel from Australia, Brazil, China, Colombia, France, Germany, Hong Kong, India, Mexico, Taiwan, Tunisia, Ukraine, United Kingdom, and the United States
•    Faculty can submit multiple projects and re-submit projects from previous years

Submit projects by June 8, 2022, at 1 p.m. PT.

Questions? Visit our website or contact us.

Mitacs recognizes that due to the pandemic and the uncertainties it has created, you may be operating with limited ability to plan future research projects. Mitacs is moving forward and planning for in-person internships next summer, but we will also prepare in case travel and public health restrictions are still in place. If you have any questions, please reach out to us at helpdesk@mitacs.ca.

For more information, please contact Jill Sherman, International Research Facilitator, at intl.research@lakeheadu.ca.

The Michelson Prizes: Next Generation Grants are $150,000 research grants given annually to support promising researchers who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases.

The 2022 Michelson Prizes will be looking for research proposals human immunology and vaccine research.  The committee will be looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development.

The application portal for the 2022 Michelson Prizes will be open until June 26, 2022.  For more information about the prizes, please visit www.humanvaccinesproject.org/michelsonprizes.

For more information, please contact Jill Sherman, International Research Facilitator, at intl.research@lakeheadu.ca